NSC |
Compound |
Enrichment |
Correlation |
NSC 652168 |
Null |
0.0438391811600409 |
0.0068888956 |
NSC 658372 |
Null |
0.0438391811600409 |
0.52910018 |
NSC 668476 |
Null |
0.0438391811600409 |
0.29768346 |
NSC 669732 |
Null |
0.0438391811600409 |
0.27517343 |
NSC 675000 |
Null |
0.0438391811600409 |
0.25462808 |
NSC 676779 |
Olean-12-en-28-oic acid, 3-.beta.-[3-O-(.beta.-L-arabinopyranosyl)- 6-methyl-.beta.-D-glucopyranuronosyloxy]-, [2-O-[[4-O-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-xylopyranosyl]-3-O-(.beta.-D-xylop |
0.0438391811600409 |
-0.1513631 |
NSC 677598 |
Glutamamide, N-acetyl-1-O-(phenylmethyl)-.alpha.-normuramyl-prolyl- N(5)-[5-[(1-nitro-9-acridinyl)amino]pentyl]-, stereoisomer |
0.0438391811600409 |
0.21188619 |
NSC 678925 |
1-Phenazinecarboxamide, N-[2-(dimethylamino)ethyl]- 9-fluoro-, monohydrochloride |
0.0438391811600409 |
0.59441694 |
NSC 681239 |
Bortezomib |
0.0438391811600409 |
-0.0079387255 |
NSC 682011 |
Benzimidazo[1,2-b]isoquinoline-6-carbonitrile, 7,8,9,10-tetrahydro-11-[(4-fluorophenyl)amino]- |
0.0438391811600409 |
0.27174958 |